{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:43Z","timestamp":1791229483967,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T00:00:00Z","timestamp":1376352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2393-13-161","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T20:14:53Z","timestamp":1376338493000},"source":"Crossref","is-referenced-by-count":25,"title":["Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study"],"prefix":"10.1186","volume":"13","author":[{"given":"Attila","family":"Molvarec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Gullai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Stenczer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"F\u00fcgedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Rig\u00f3 Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,13]]},"reference":[{"key":"817_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0002-9378(00)99785-0","volume":"183","author":"National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy","year":"2000","unstructured":"National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy: Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000, 183: S1-S22.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(00)02800-2","volume":"56","author":"JJ Walker","year":"2000","unstructured":"Walker JJ: Pre-eclampsia. Lancet. 2000, 56: 1260-1265.","journal-title":"Lancet"},{"key":"817_CR3","doi-asserted-by":"publisher","first-page":"f108","DOI":"10.1136\/bmj.f108","volume":"346","author":"J Gardosi","year":"2013","unstructured":"Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A: Maternal and fetal risk factors for stillbirth: population based study. Brit Med J. 2013, 346: f108-10.1136\/bmj.f108.","journal-title":"Brit Med J"},{"key":"817_CR4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.preghy.2011.08.117","volume":"2","author":"UB Knudsen","year":"2012","unstructured":"Knudsen UB, Kronborg CS, von-Dadelszen P, Kupfer K, Lee S-W, Vittinghus E, Allen JG, Redman CW: A single rapid point of care placental growth factor determination as an aid in the diagnosis of preeclampsia. Pregnancy Hypertens. 2012, 2: 8-15.","journal-title":"Pregnancy Hypertens"},{"key":"817_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004, 350: 672-683. 10.1056\/NEJMoa031884.","journal-title":"N Engl J Med"},{"key":"817_CR6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","volume":"50","author":"A Hertig","year":"2004","unstructured":"Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, Uzan S, Rondeau E: Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem. 2004, 50: 1702-1703. 10.1373\/clinchem.2004.036715.","journal-title":"Clin Chem"},{"key":"817_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ajog.2004.03.004","volume":"191","author":"GC McKeeman","year":"2004","unstructured":"McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N: Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004, 191: 1240-1246. 10.1016\/j.ajog.2004.03.004.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR8","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1210\/jc.2004-1955","volume":"90","author":"E Shibata","year":"2005","unstructured":"Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA: Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005, 90: 4895-4903. 10.1210\/jc.2004-1955.","journal-title":"J Clin Endocrinol Metab"},{"key":"817_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3346\/jkms.2007.22.5.873","volume":"22","author":"SY Kim","year":"2007","unstructured":"Kim SY, Ryu HM, Yang JH, Kim MY, Han JY, Kim JO, Chung JH, Park SY, Lee MH, Kim DJ: Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia. J Korean Med Sci. 2007, 22: 873-877. 10.3346\/jkms.2007.22.5.873.","journal-title":"J Korean Med Sci"},{"key":"817_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","volume":"179","author":"DS Torry","year":"1998","unstructured":"Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ: Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998, 179: 1539-1544. 10.1016\/S0002-9378(98)70021-3.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1067\/mob.2003.111","volume":"188","author":"RN Taylor","year":"2003","unstructured":"Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol. 2003, 188: 177-182. 10.1067\/mob.2003.111.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","volume":"106","author":"A Reuvekamp","year":"1999","unstructured":"Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ: Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 1999, 106: 1019-1022. 10.1111\/j.1471-0528.1999.tb08107.x.","journal-title":"Br J Obstet Gynaecol"},{"key":"817_CR13","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1067\/mob.2000.108022","volume":"183","author":"JC Livingston","year":"2000","unstructured":"Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM: Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol. 2000, 183: 1554-1557. 10.1067\/mob.2000.108022.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR14","first-page":"e1","volume":"202:40","author":"S Sunderji","year":"2010","unstructured":"Sunderji S, Gaziano E, Wothe D, Rogers LC, Sibai B, Karumanchi SA, Hodges-Savola C: Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol. 2010, 202:40: e1-7.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/00016340802253759","volume":"87","author":"A De-Vivo","year":"2008","unstructured":"De-Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D\u2019Anna R: Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand. 2008, 87: 837-842. 10.1080\/00016340802253759.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"817_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/hr.2010.15","volume":"33","author":"A Ohkuchi","year":"2010","unstructured":"Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, Suzuki M: Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010, 33: 422-427. 10.1038\/hr.2010.15.","journal-title":"Hypertens Res"},{"key":"817_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3109\/14767050902994754","volume":"22","author":"JP Kusanovic","year":"2009","unstructured":"Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS: A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009, 22: 1021-1038. 10.3109\/14767050902994754.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"817_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/AOG.0b013e3181719b7a","volume":"111","author":"JH Lim","year":"2008","unstructured":"Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM: Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol. 2008, 111: 1403-1409. 10.1097\/AOG.0b013e3181719b7a.","journal-title":"Obstet Gynecol"},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/hr.2010.92","volume":"33","author":"A Molvarec","year":"2010","unstructured":"Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigo J: Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res. 2010, 33: 892-898. 10.1038\/hr.2010.92.","journal-title":"Hypertens Res"},{"key":"817_CR20","first-page":"e1","volume":"202:161","author":"S Verlohren","year":"2010","unstructured":"Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H: An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010, 202:161: e1-11.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR21","doi-asserted-by":"publisher","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","volume":"5","author":"RW Powers","year":"2010","unstructured":"Powers RW, Jeyabalan A, Clifton RG, Van-Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M, Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network: Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One. 2010, 5: e13263-10.1371\/journal.pone.0013263.","journal-title":"PLoS One"},{"key":"817_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1447-0756.2009.01037.x","volume":"35","author":"VD Nadarajah","year":"2009","unstructured":"Nadarajah VD, Min RG, Judson JP, Jegasothy R, Ling EH: Maternal plasma soluble fms-like tyrosine kinase-1 and placental growth factor levels as biochemical markers of gestational hypertension for Malaysian mothers. J Obstet Gynaecol Res. 2009, 35: 855-863. 10.1111\/j.1447-0756.2009.01037.x.","journal-title":"J Obstet Gynaecol Res"},{"key":"817_CR23","doi-asserted-by":"publisher","first-page":"e2766","DOI":"10.1371\/journal.pone.0002766","volume":"3","author":"A Khalil","year":"2008","unstructured":"Khalil A, Muttukrishna S, Harrington K, Jauniaux E: Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders. PLoS One. 2008, 3: e2766-10.1371\/journal.pone.0002766.","journal-title":"PLoS One"},{"key":"817_CR24","first-page":"e1","volume":"206:58","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H: The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012, 206:58: e1-8.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/hr.2012.206","volume":"36","author":"N Gullai","year":"2013","unstructured":"Gullai N, Stenczer B, Molvarec A, Fugedi G, Veresh Z, Nagy B, Rigo J: Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy. Hypertens Res. 2013, 36: 457-462. 10.1038\/hr.2012.206.","journal-title":"Hypertens Res"},{"key":"817_CR26","doi-asserted-by":"crossref","unstructured":"Chaiworapongsa T, Romero R, Korzeniewski SJ, Cortez JM, Pappas A, Tarca AL, Chaemsaithong P, Dong Z, Yeo L, Hassan SS: Plasma concentrations of angiogenic\/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med. in press. \n                    http:\/\/dx.doi.org\/10.3109\/14767058.2013.806905","DOI":"10.3109\/14767058.2013.806905"},{"key":"817_CR27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2013.01.004","volume":"3","author":"C Saffer","year":"2013","unstructured":"Saffer C, Olson G, Boggess KA, Beyerlein R, Eubank C, Sibai BM, the NORMALS Study Group: Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens. 2013, 3: 124-132.","journal-title":"Pregnancy Hypertens"},{"key":"817_CR28","first-page":"e1","volume":"206:163","author":"SJ Benton","year":"2012","unstructured":"Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von-Dadelszen P: Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?. Am J Obstet Gynecol. 2012, 206:163: e1-7.","journal-title":"Am J Obstet Gynecol"},{"key":"817_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/uog.3930","volume":"29","author":"D Schlembach","year":"2007","unstructured":"Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW, Lang U: Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2007, 29: 407-413. 10.1002\/uog.3930.","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-13-161\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-13-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-13-161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-13-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:00:46Z","timestamp":1548126046000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-13-161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-13-161","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,13]]},"article-number":"161"}}